These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 20130653)
1. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Cady SD; Schmidt-Rohr K; Wang J; Soto CS; Degrado WF; Hong M Nature; 2010 Feb; 463(7281):689-92. PubMed ID: 20130653 [TBL] [Abstract][Full Text] [Related]
2. Structural basis for the function and inhibition of an influenza virus proton channel. Stouffer AL; Acharya R; Salom D; Levine AS; Di Costanzo L; Soto CS; Tereshko V; Nanda V; Stayrook S; DeGrado WF Nature; 2008 Jan; 451(7178):596-9. PubMed ID: 18235504 [TBL] [Abstract][Full Text] [Related]
3. Structure of amantadine-bound M2 transmembrane peptide of influenza A in lipid bilayers from magic-angle-spinning solid-state NMR: the role of Ser31 in amantadine binding. Cady SD; Mishanina TV; Hong M J Mol Biol; 2009 Jan; 385(4):1127-41. PubMed ID: 19061899 [TBL] [Abstract][Full Text] [Related]
4. Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel. Chuang GY; Kozakov D; Brenke R; Beglov D; Guarnieri F; Vajda S Biophys J; 2009 Nov; 97(10):2846-53. PubMed ID: 19917240 [TBL] [Abstract][Full Text] [Related]
5. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647 [TBL] [Abstract][Full Text] [Related]
6. Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus. Khurana E; Devane RH; Dal Peraro M; Klein ML Biochim Biophys Acta; 2011 Feb; 1808(2):530-7. PubMed ID: 20385097 [TBL] [Abstract][Full Text] [Related]
7. Where does amantadine bind to the influenza virus M2 proton channel? Kozakov D; Chuang GY; Beglov D; Vajda S Trends Biochem Sci; 2010 Sep; 35(9):471-5. PubMed ID: 20382026 [TBL] [Abstract][Full Text] [Related]
8. Structure and function of the influenza A M2 proton channel. Cady SD; Luo W; Hu F; Hong M Biochemistry; 2009 Aug; 48(31):7356-64. PubMed ID: 19601584 [TBL] [Abstract][Full Text] [Related]
9. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696 [TBL] [Abstract][Full Text] [Related]
10. pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus. Salom D; Hill BR; Lear JD; DeGrado WF Biochemistry; 2000 Nov; 39(46):14160-70. PubMed ID: 11087364 [TBL] [Abstract][Full Text] [Related]
11. The boundary lipid around DMPC-spanning influenza A M2 transmembrane domain channels: Its structure and potential for drug accommodation. Konstantinidi A; Chountoulesi M; Naziris N; Sartori B; Amenitsch H; Mali G; Čendak T; Plakantonaki M; Triantafyllakou I; Tselios T; Demetzos C; Busath DD; Mavromoustakos T; Kolocouris A Biochim Biophys Acta Biomembr; 2020 Mar; 1862(3):183156. PubMed ID: 31846647 [TBL] [Abstract][Full Text] [Related]
12. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers. Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183 [TBL] [Abstract][Full Text] [Related]
13. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus. Du QS; Huang RB; Wang SQ; Chou KC PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344 [TBL] [Abstract][Full Text] [Related]
14. X-ray Crystal Structure of the Influenza A M2 Proton Channel S31N Mutant in Two Conformational States: An Open and Shut Case. Thomaston JL; Wu Y; Polizzi N; Liu L; Wang J; DeGrado WF J Am Chem Soc; 2019 Jul; 141(29):11481-11488. PubMed ID: 31184871 [TBL] [Abstract][Full Text] [Related]
15. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus. Balannik V; Wang J; Ohigashi Y; Jing X; Magavern E; Lamb RA; Degrado WF; Pinto LH Biochemistry; 2009 Dec; 48(50):11872-82. PubMed ID: 19905033 [TBL] [Abstract][Full Text] [Related]
16. Interpreting Thermodynamic Profiles of Aminoadamantane Compounds Inhibiting the M2 Proton Channel of Influenza A by Free Energy Calculations. Homeyer N; Ioannidis H; Kolarov F; Gauglitz G; Zikos C; Kolocouris A; Gohlke H J Chem Inf Model; 2016 Jan; 56(1):110-26. PubMed ID: 26690735 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced conformational and dynamical changes of the S31N mutant of the influenza M2 proton channel investigated by solid-state NMR. Williams JK; Tietze D; Wang J; Wu Y; DeGrado WF; Hong M J Am Chem Soc; 2013 Jul; 135(26):9885-97. PubMed ID: 23758317 [TBL] [Abstract][Full Text] [Related]
18. Membrane-dependent effects of a cytoplasmic helix on the structure and drug binding of the influenza virus M2 protein. Cady S; Wang T; Hong M J Am Chem Soc; 2011 Aug; 133(30):11572-9. PubMed ID: 21661724 [TBL] [Abstract][Full Text] [Related]
19. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus. Du QS; Huang RB; Wang CH; Li XM; Chou KC J Theor Biol; 2009 Jul; 259(1):159-64. PubMed ID: 19285514 [TBL] [Abstract][Full Text] [Related]
20. A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine. Yi M; Cross TA; Zhou HX J Phys Chem B; 2008 Jul; 112(27):7977-9. PubMed ID: 18476738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]